BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21479840)

  • 21. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.
    Lockhart SR; Messer SA; Pfaller MA; Diekema DJ
    J Clin Microbiol; 2008 Aug; 46(8):2659-64. PubMed ID: 18562582
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
    J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
    [No Abstract]   [Full Text] [Related]  

  • 23. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
    Cordeiro RA; Macedo RB; Teixeira CEC; Marques FJF; Bandeira TJPG; Moreira JLB; Brilhante RSN; Rocha MFG; Sidrim JJC
    J Med Microbiol; 2014 Jul; 63(Pt 7):936-944. PubMed ID: 24722799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
    González GM; Elizondo M; Ayala J
    J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections.
    Tay ST; Na SL; Chong J
    J Med Microbiol; 2009 Feb; 58(Pt 2):185-191. PubMed ID: 19141735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina.
    Vigezzi C; Icely PA; Dudiuk C; Rodríguez E; Miró MS; Castillo GDV; Azcurra AI; Abiega C; Caeiro JP; Riera FO; García-Effrón G; Sotomayor CE
    J Mycol Med; 2019 Dec; 29(4):285-291. PubMed ID: 31668524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates.
    Ahmadi A; Mahmoudi S; Rezaie S; Hashemi SJ; Dannaoui E; Badali H; Ghaffari M; Aala F; Izadi A; Maleki A; Meis JF; Khodavaisy S
    J Glob Antimicrob Resist; 2020 Jun; 21():331-334. PubMed ID: 31715297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.
    De Francesco MA; Piccinelli G; Gelmi M; Gargiulo F; Ravizzola G; Pinsi G; Peroni L; Bonfanti C; Caruso A
    Mycopathologia; 2017 Oct; 182(9-10):897-905. PubMed ID: 28597394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.
    González GM; Treviño-Rangel Rde J; Palma-Nicolás JP; Martínez C; González JG; Ayala J; Caballero A; Morfín-Otero R; Rodríguez-Noriega E; Velarde F; Ascencio EP; Tinoco JC; Vázquez JA; Cano MA; León-Sicairos N; González R; Rincón J; Elías MA; Bonifaz A
    J Antimicrob Chemother; 2013 Dec; 68(12):2847-51. PubMed ID: 23869052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.
    Liu W; Tan J; Sun J; Xu Z; Li M; Yang Q; Shao H; Zhang L; Liu W; Wan Z; Cui W; Zang B; Jiang D; Fang Q; Qin B; Qin T; Li W; Guo F; Liu D; Guan X; Yu K; Qiu H; Li R;
    J Antimicrob Chemother; 2014 Jan; 69(1):162-7. PubMed ID: 24004860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.
    Ruiz LS; Khouri S; Hahn RC; da Silva EG; de Oliveira VK; Gandra RF; Paula CR
    Mycopathologia; 2013 Apr; 175(3-4):231-9. PubMed ID: 23404576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the Candida parapsilosis complex in East China: species distribution differs among cities.
    Ge YP; Boekhout T; Zhan P; Lu GX; Shen YN; Li M; Shao HF; Liu WD
    Med Mycol; 2012 Jan; 50(1):56-66. PubMed ID: 21728755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
    Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
    J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts,
    Arastehfar A; Khodavaisy S; Daneshnia F; Najafzadeh MJ; Mahmoudi S; Charsizadeh A; Salehi MR; Zarrinfar H; Raeisabadi A; Dolatabadi S; Zare Shahrabadi Z; Zomorodian K; Pan W; Hagen F; Boekhout T
    Front Cell Infect Microbiol; 2019; 9():264. PubMed ID: 31417877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant differences in drug susceptibility among species in the Candida parapsilosis group.
    van Asbeck E; Clemons KV; Martinez M; Tong AJ; Stevens DA
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):106-9. PubMed ID: 18555634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
    New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.
    Farooqi JQ; Jabeen K; Saeed N; Iqbal N; Malik B; Lockhart SR; Zafar A; Brandt ME; Hasan R
    J Med Microbiol; 2013 Feb; 62(Pt 2):259-268. PubMed ID: 23105021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.